论文部分内容阅读
目的:探讨贝那普利联合氨氯地平治疗原发性高血压的临床应用价值。方法:选取我院2016年8月-2017年6月收治的108例原发性高血压患者作为本次研究对象,按照随机数表法分为对照组与观察组,每组各54例。对照组采用贝那普利进行治疗,观察组采用贝那普利联合氨氯地平进行治疗。比较两组治疗前后收缩压、舒张压以及治疗有效率。结果:观察组治疗有效率高于对照组,而收缩压、舒张压低于对照组,差异显著(P<0.05)。结论:采用贝那普利联合氨氯地平治疗原发性高血压疗效显著,值得进一步推广。
Objective: To investigate the clinical value of benazepril combined with amlodipine in the treatment of essential hypertension. Methods: A total of 108 patients with essential hypertension admitted in our hospital from August 2016 to June 2017 were selected as the study subjects and divided into control group and observation group according to the random number table method, with 54 cases in each group. The control group was treated with benazepril, the observation group with benazepril combined with amlodipine for treatment. Before and after treatment, systolic blood pressure, diastolic blood pressure and treatment efficiency were compared between the two groups. Results: The effective rate of observation group was higher than that of control group, while systolic pressure and diastolic pressure were lower than those of control group (P <0.05). Conclusion: The effect of benazepril combined with amlodipine in the treatment of essential hypertension is significant and worthy of further promotion.